Keywords
Sorbact
Silver Sulfadiazine
Comparative Study
Wound Healing
Split-thickness Skin Graft
Low- and Middle-income Countries
Burn Management
How to Cite
Abstract
Introduction. Low- and middle-income countries (LMICs) bear a disproportionate burden of burn injuries, which continue to be a major worldwide health concern. A distinct class of burn injuries known as chemical burns is distinguished by the possibility of profound skin degradation and progressive tissue damage. Although delayed epithelialization and cytotoxic effects on regenerating tissue have been concerns, silver sulfadiazine (SSD) has long been regarded as the standard topical antibacterial therapy in burn care. In order to bind germs without releasing active antimicrobial drugs and perhaps maintain tissue viability, Sorbact® bacteriostatic dressings use hydrophobic interaction technology. The purpose of this pilot comparative study was to evaluate the clinical results of 1% SSD and Sorbact® dressings for patients with partial-thickness chemical burns in a context with limited resources.
Methods. This single-center pilot comparative study was conducted at the Burn Care Centre, Pakistan Institute of Medical Sciences (PIMS), Islamabad. Sixty adult patients who presented within 6 hours of sustaining partial-thickness chemical burns involving ≤30% total body surface area (TBSA) were randomized in a 1:1 ratio in a institutional clinical trial software to receive either Sorbact® dressings or 1% SSD. All patients received standardized supportive management as per institutional protocol including intravenous analgesia, fluid resuscitation, and systemic antibiotics (Piperacillin–Tazobactam) as per institutional protocol. The primary outcome was time to complete epithelialization of the wound. Secondary outcomes included hospital stay duration, need for split-thickness skin grafting (STSG) and dressing frequency.
Results. The study included 60 patients (63.3% female) with a mean TBSA of 23.3%, most commonly involving the trunk (n=22) and face (n=16), with comparable baseline characteristics between groups. Mean time to complete epithelialization was significantly shorter in the Sorbact® group. Hospital stay duration was reduced in the Sorbact® group, and fewer patients required STSG. No systemic infections were documented in either group.
Discussion. In this pilot single-center study, Sorbact® dressings demonstrated favorable clinical outcomes compared with 1% SSD in partial-thickness chemical burns. Given the unique nature of study and limited sample size, large multicenter trials are required to confirm these findings and evaluate cost-effectiveness in LMIC settings.
References
1. World Health Organization. Burns. Geneva: World Health Organization; 2023 [cited 2026 Mar 2]. Available from: https://www.who.int/news-room/fact-sheets/detail/burns
2. Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6:11. https://doi.org/10.1038/s41572-020-0145-5
3. Smolle C, Cambiaso-Daniel J, Forbes AA, et al. Recent trends in burn epidemiology worldwide: a systematic review. Burns. 2023;49(2):345–356. https://doi.org/10.1016/j.burns.2022.08.012
4. Greenhalgh DG. Burn wound healing and management in 2022. N Engl J Med. 2022;386:2349–2359. https://doi.org/10.1056/NEJMra2113400
5. Finnerty CC, Jeschke MG, Branski LK, et al. Hypertrophic scarring and epithelial regeneration after burn injury. Lancet. 2023;401:1925–1938. https://doi.org/10.1016/S0140-6736(23)00541-9
6. Rowan MP, Cancio LC, Elster EA, et al. Burn wound healing and treatment: recent advances. Crit Care. 2022;26:243. https://doi.org/10.1186/s13054-022-04133-4
7. Nherera LM, Trueman P, Roberts CD, Berg L. A systematic review and meta-analysis of silver sulfadiazine versus modern dressings in burns. Burns. 2021;47(8):1802–1814. https://doi.org/10.1016/j.burns.2021.05.012
8. Poon VKM, Burd A. Silver toxicity in wound management: clinical implications. Burns. 2021;47(5):1019–1028. https://doi.org/10.1016/j.burns.2020.12.019
9. Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H. Topical silver for preventing wound infection: updated systematic review. Cochrane Database Syst Rev. 2022;(6):CD006478. https://doi.org/10.1002/14651858.CD006478.pub4
10. Totty JP, Bua N, Smith GE, et al. Clinical effectiveness of dialkylcarbamoyl chloride (DACC) dressings: updated evidence review. J Wound Care. 2021;30(Sup6):S6–S15. https://doi.org/10.12968/jowc.2021.30.Sup6.S6
11. Percival SL, Suleman L, Vuotto C, Donelli G. Mechanisms of action of hydrophobic DACC dressings. Int Wound J. 2022;19(4):678–689. https://doi.org/10.1111/iwj.13756
12. Kramer A, Dissemond J, Kim S, et al. Consensus on antimicrobial stewardship in wound care. J Wound Care. 2022;31(Sup4):S1–S28. https://doi.org/10.12968/jowc.2022.31.Sup4.S1
13. Peck MD, Kruger GE, van der Merwe AE, et al. Burns in low- and middle-income countries: global disparities and solutions. Burns. 2022;48(3):521–530. https://doi.org/10.1016/j.burns.2021.10.004
14. Gupta S, Wong EG, Stewart BT, et al. Cost of burn care in low-resource settings. World J Surg. 2023;47:1550–1558. https://doi.org/10.1007/s00268-023-06982-5
15. Aziz Z, Abu SF, Chong NJ. A systematic review of advanced dressings in partial-thickness burns. Burns. 2021;47(7):1560–1571. https://doi.org/10.1016/j.burns.2021.01.015
16. Wu J, Liu Y, Zhang R, Chen H, Li X. Effect of silver-containing hydrofiber dressing on burn wound healing compared with silver sulfadiazine. J Cosmet Dermatol. 2023;22(5):1605-12. https://doi.org/10.1111/jocd.15639
17. Šuca H, Smrkolj V, et al. Current approaches to wound repair in burns: progress from wound cover to wound closure. J Surg Res. 2024;293:192-204. https://doi.org/10.1016/j.jss.2023.10.023.
18. Jackson DM. The diagnosis of the depth of burning. Burns Trauma. 2023;11:tkad019. https://doi.org/10.1093/burnst/tkad019
19. Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2022;4:CD002106. https://doi.org/10.1002/14651858.CD002106.pub6.
20. Cooper R, Jenkins L. A comparison between DACC-coated dressings and antimicrobial dressings in wound management. J Wound Care. 2023;32(3):140-146. https://doi.org/10.12968/jowc.2023.32.3.140.
21. Mosti G, Partsch H. Bacterial binding and removal from chronic wounds using a dialkylcarbamoyl chloride (DACC)-coated dressing. J Wound Care. 2022;31(Sup6):S4-S10. https://doi.org/10.12968/jowc.2022.31.Sup6.S4.
22. Brusselaers N, Pirayesh A, Hoeksema H, et al. Predictors of grafting in deep dermal burns. Burns. 2022;48(2):337–345. https://doi.org/10.1016/j.burns.2021.05.020
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Ali Mujtaba, Samin Khan, Muhammad Hassaan Tariq, Sanila Ayub, Mahvish Aftab Khan, Muhammad Usman Ali, Muhammad Ibrahim, Nimrah Komal, Tariq Iqbal, Muhammad Rehan